Is truxima a biosimilar of rituxan?

Is Truxima a biosimilar of Rituxan?

Yes. Truxima is a biosimilar of Rituxan (rituximab). Truxima and Rituxan use the same active ingredient name, rituximab, and Truxima is made to be highly similar to Rituxan in terms of structure, intended use, and clinical performance. [1]

What does “biosimilar of Rituxan” mean in practice?

Being a biosimilar means Truxima is designed to work like Rituxan and is approved as an alternative to the original reference product (Rituxan). Biosimilars generally have the same type of treatment targets and indications as the reference product, though the exact approved indications and dosing details can depend on the product label. [1]

Who makes Truxima and what is it used for?

Truxima is a rituximab biosimilar indicated for certain cancers and autoimmune diseases, reflecting Rituxan’s general therapeutic use as a monoclonal antibody targeting CD20 on B-cells. [1]

Sources

[1] https://www.drugpatentwatch.com/p/truxima-truxima-biosimilar/